Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 3Neoplasms 2Sarcoidosis 1Prostatic Neoplasms 1Prostatic Hyperplasia 1Pancreatic Diseases 1Pancreatic Cyst 1Neuroendocrine Tumors 1Neoplastic Cells, Circulating 1Lymphoma, Follicular 1Lymphoma 1Lymphadenopathy 1Lung Neoplasms 1Lung Cancer Metastatic 1Disease 1

Interventions

Gemcitabine 3130-nm albumin-bound paclitaxel 3Blood Specimen Collection 2Albumin-Bound Paclitaxel 2sonidegib 1parecoxib 1lutetium Lu 177 dotatate 1copper dotatate CU-64 1Surveys and Questionnaires 1Sunitinib 1Rehabilitation 1Postoperative Care 1Piperacillin, Tazobactam Drug Combination 1Needles 1Methods 1Lutetium-177 1Lutetium 1Irinotecan 1Histocompatibility Testing 1HhAntag691 1Duodenoscopes 1Drainage 1Cisplatin 1Cefoxitin 1Capecitabine 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pancreatic Diseases × Needles × Clear all
NCT02092519 2015-07-29

RCT: Difference in Diagnostic Yield Between EUSFNA Needles With and Without a Side Port in Pancreatic Masses

Changi General Hospital

Phase 4 Completed
40 enrolled
Gastrointestinal

Pancreatic Diseases, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡